353 related articles for article (PubMed ID: 27862414)
1. Epidemiology and cost implications of candidemia, a 6-year analysis from a developing country.
Ulu Kilic A; Alp E; Cevahir F; Ture Z; Yozgat N
Mycoses; 2017 Mar; 60(3):198-203. PubMed ID: 27862414
[TBL] [Abstract][Full Text] [Related]
2. Epidemiology, risk factor, species distribution, antifungal resistance and outcome of Candidemia at a single French hospital: a 7-year study.
Tadec L; Talarmin JP; Gastinne T; Bretonnière C; Miegeville M; Le Pape P; Morio F
Mycoses; 2016 May; 59(5):296-303. PubMed ID: 26806101
[TBL] [Abstract][Full Text] [Related]
3. Seven-year trend analysis of nosocomial candidemia and antifungal (fluconazole and caspofungin) use in Intensive Care Units at a Brazilian University Hospital.
Girão E; Levin AS; Basso M; Gobara S; Gomes LB; Medeiros EA; Costa SF
Med Mycol; 2008 Sep; 46(6):581-8. PubMed ID: 19180727
[TBL] [Abstract][Full Text] [Related]
4. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
5. Candida orthopsilosis fungemias in a Spanish tertiary care hospital: incidence, epidemiology and antifungal susceptibility.
Blanco-Blanco MT; Gómez-García AC; Hurtado C; Galán-Ladero MA; Lozano Mdel C; García-Tapias A; Blanco MT
Rev Iberoam Micol; 2014; 31(2):145-8. PubMed ID: 23680638
[TBL] [Abstract][Full Text] [Related]
6. [Epidemiology, species, antifungal resistance and outcome of candidemia in a university hospital in Buenos Aires, Argentina for 16 years].
Tiraboschi IN; Pozzi NC; Farías L; García S; Fernández NB
Rev Chilena Infectol; 2017 Oct; 34(5):431-440. PubMed ID: 29488584
[TBL] [Abstract][Full Text] [Related]
7. Recent exposure to caspofungin or fluconazole influences the epidemiology of candidemia: a prospective multicenter study involving 2,441 patients.
Lortholary O; Desnos-Ollivier M; Sitbon K; Fontanet A; Bretagne S; Dromer F;
Antimicrob Agents Chemother; 2011 Feb; 55(2):532-8. PubMed ID: 21078946
[TBL] [Abstract][Full Text] [Related]
8. Is the incidence of candidemia caused by Candida glabrata increasing in Brazil? Five-year surveillance of Candida bloodstream infection in a university reference hospital in southeast Brazil.
Moretti ML; Trabasso P; Lyra L; Fagnani R; Resende MR; de Oliveira Cardoso LG; Schreiber AZ
Med Mycol; 2013 Apr; 51(3):225-30. PubMed ID: 22920712
[TBL] [Abstract][Full Text] [Related]
9. Population-Based Active Surveillance for Culture-Confirmed Candidemia - Four Sites, United States, 2012-2016.
Toda M; Williams SR; Berkow EL; Farley MM; Harrison LH; Bonner L; Marceaux KM; Hollick R; Zhang AY; Schaffner W; Lockhart SR; Jackson BR; Vallabhaneni S
MMWR Surveill Summ; 2019 Sep; 68(8):1-15. PubMed ID: 31557145
[TBL] [Abstract][Full Text] [Related]
10. Epidemiology of candidemia and antifungal susceptibility in invasive Candida species in the Asia-Pacific region.
Wang H; Xu YC; Hsueh PR
Future Microbiol; 2016 Oct; 11():1461-1477. PubMed ID: 27750452
[TBL] [Abstract][Full Text] [Related]
11. Antimicrobial susceptibility and clinical outcomes of Candida parapsilosis bloodstream infections in a tertiary teaching hospital in Northern Taiwan.
Lin CC; Liu CP; Hsieh FC; Lee CM; Wang WS
J Microbiol Immunol Infect; 2015 Oct; 48(5):552-8. PubMed ID: 25315213
[TBL] [Abstract][Full Text] [Related]
12. Epidemiological changes with potential implication for antifungal prescription recommendations for fungaemia: data from a nationwide fungaemia surveillance programme.
Arendrup MC; Dzajic E; Jensen RH; Johansen HK; Kjaeldgaard P; Knudsen JD; Kristensen L; Leitz C; Lemming LE; Nielsen L; Olesen B; Rosenvinge FS; Røder BL; Schønheyder HC
Clin Microbiol Infect; 2013 Aug; 19(8):E343-53. PubMed ID: 23607326
[TBL] [Abstract][Full Text] [Related]
13. [Emergence of Candida parapsilosis candidemia at Cochin hospital. Characterization of isolates and search for risk factors].
Paugam A; Baixench MT; Taieb F; Champagnac C; Dupouy-Camet J
Pathol Biol (Paris); 2011 Feb; 59(1):44-7. PubMed ID: 20889268
[TBL] [Abstract][Full Text] [Related]
14. Prevalence, virulence factors and antifungal susceptibility of Candida spp. isolated from bloodstream infections in a tertiary care hospital in Brazil.
Canela HMS; Cardoso B; Vitali LH; Coelho HC; Martinez R; Ferreira MEDS
Mycoses; 2018 Jan; 61(1):11-21. PubMed ID: 28940753
[TBL] [Abstract][Full Text] [Related]
15. Candidemia surveillance in Iowa: emergence of echinocandin resistance.
Matsumoto E; Boyken L; Tendolkar S; McDanel J; Castanheira M; Pfaller M; Diekema D
Diagn Microbiol Infect Dis; 2014 Jun; 79(2):205-8. PubMed ID: 24666704
[TBL] [Abstract][Full Text] [Related]
16. [Epidemiology and antifungal susceptibility of species producing candidemia in Valdivia, Chile].
Márquez F; Iturrieta I; Calvo M; Urrutia M; Godoy-Martínez P
Rev Chilena Infectol; 2017 Oct; 34(5):441-446. PubMed ID: 29488585
[TBL] [Abstract][Full Text] [Related]
17. Nosocomial bloodstream infections due to Candida spp. in the USA: species distribution, clinical features and antifungal susceptibilities.
Wisplinghoff H; Ebbers J; Geurtz L; Stefanik D; Major Y; Edmond MB; Wenzel RP; Seifert H
Int J Antimicrob Agents; 2014 Jan; 43(1):78-81. PubMed ID: 24182454
[TBL] [Abstract][Full Text] [Related]
18. Antifungal susceptibility of Candida species isolated from patients with candidemia in southern Taiwan, 2007-2012: impact of new antifungal breakpoints.
Chen YC; Kuo SF; Chen FJ; Lee CH
Mycoses; 2017 Feb; 60(2):89-95. PubMed ID: 27621210
[TBL] [Abstract][Full Text] [Related]
19. Increasing incidence of Candida parapsilosis candidemia with caspofungin usage.
Forrest GN; Weekes E; Johnson JK
J Infect; 2008 Feb; 56(2):126-9. PubMed ID: 18082269
[TBL] [Abstract][Full Text] [Related]
20. [Epidemiological and microbiological evaluation of nosocomial infections caused by Candida species].
Erdem F; Tuncer Ertem G; Oral B; Karakoç E; Demiröz AP; Tülek N
Mikrobiyol Bul; 2012 Oct; 46(4):637-48. PubMed ID: 23188577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
